ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Rheumatic Diseases

Rheumatic Diseases

The patient’s reach with his thumb helps distinguish between frozen shoulder and osteoarthritis. How high is enough to tell?

©Guschenkova/Shutterstock.com

Research points to the promise of rituximab as a second-line option for patients who do not respond to anti-TNF agents.

©BrianChase/Shutterstock.com

Sleep apnea and gout have a lot in common: Both are associated with an increased level of uric acid and the incidence of gout.

Adalimumab improves function and quality of life for patients with uveitis, shows a study presented at 2015 ACR/ARHP.

©Maltsev Semion/Shutterstock.com

ELISA yields more consistent quantitative and qualitative results when measuring adalimumab and infliximab levels.

©Lightspring/Shuttersstock.com

Anti-CarP antibodies associated with increased disability and higher disease activity in patients with inflammatory polyarthritis.

©Garsya/Shuttersstock.com

A Clinical and Experimental Rheumatology review offers a critical analysis of recent studies on systemic sclerosis to best classify and manage this chronic condition.

Pages

Subscribe to Rheumatic Diseases on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.